Consensus AngioDynamics, Inc.

Stocks

ANGO

US03475V1017

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 00:00:00 27/10/2026 +04			5-day change	1st Jan Change
12.17 ^USD	-1.58%		+6.85%	-5.22%

10-21	Angiodynamics, Inc. Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic Ire	CI
10-14	AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer	CI

Evolution of the Average Target: AngioDynamics, Inc.

Evolution of the Target Price: AngioDynamics, Inc.

Changes in Analyst Recommendations: AngioDynamics, Inc.

d9d02e.JdeOILTNumBJsqRHsP0Bi8qEKZjZEOSYFebJ-B3N5hw.ceHbGPb__iwY7ZEx8bpH0r_jWqqUcojiJdagtjCS01URtrx2gqv3ExrV6Q~734aa923f3c6aacbca620da8a866b69c

Analysts' recommendations: AngioDynamics, Inc.

15/07/25	Medical device maker AngioDynamics beats Q4 revenue estimates	RE
05/04/24	Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target	MT
09/01/24	Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating	MT
08/01/24	HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating	MT
06/10/23	Raymond James Adjusts Price Target on AngioDynamics to $12 From $13, Keeps Outperform Rating	MT
05/10/23	HC Wainwright Adjusts AngioDynamics' Price Target to $20 From $19, Keeps Buy Rating	MT
25/09/23	HC Wainwright Starts AngioDynamics at Buy With $19 Price Target	MT
13/07/23	Canaccord Genuity Adjusts AngioDynamics Price Target to $20 From $18, Maintains Buy Rating	MT
17/04/23	Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14	MT
03/04/23	Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong Buy Rating	MT
06/01/23	Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating	MT
07/10/22	Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy Rating	MT
13/07/22	Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rating	MT
15/10/21	AngioDynamics : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Target to $37 From $28	MT
20/08/21	AngioDynamics : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rating	MT
14/07/21	AngioDynamics : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 From $24, Maintains Hold Rating	MT
09/07/21	AngioDynamics : Raymond James Adjusts AngioDynamics' Price Target to $32 From $27, Keeps Strong Buy Rating	MT
31/03/21	AngioDynamics : Raymond James Adjusts AngioDynamics' Price Target to $27 from $24, Keeps Strong Buy Rating	MT
31/03/21	AngioDynamics : Canaccord Genuity Adjusts Price Target on AngioDynamics to $24 From $18, Maintains Hold Rating	MT
25/11/20	AngioDynamics : Raymond James Upgrades AngioDynamics to Strong Buy From Market Perform; Price Target is $18	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ANGIODYNAMICS, INC.					+59.73%
	ABBOTT LABORATORIES					+14.29%
	STRYKER CORPORATION					+18.06%
	MEDTRONIC PLC					+9.65%
	ESSILORLUXOTTICA					+19.16%
	CENCORA, INC.					+11.51%
	HOYA CORPORATION					+17.34%
	BECTON, DICKINSON AND COMPANY					-1.68%
	IDEXX LABORATORIES, INC.					+24.56%
	ALCON INC.					+29.2%
	Average					+20.18%
	Weighted average by Cap.					+14.91%